You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
|
|---|---|
| Published in |
Lancet Neurology, March 2023
|
| DOI | 10.1016/s1474-4422(22)00517-8 |
| Pubmed ID | |
| Authors |
Richard B Lipton, Robert Croop, David A Stock, Jennifer Madonia, Micaela Forshaw, Meghan Lovegren, Linda Mosher, Vladimir Coric, Peter J Goadsby |
X Demographics
The data shown below were collected from the profiles of 55 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 14 | 25% |
| Spain | 2 | 4% |
| Sweden | 2 | 4% |
| United Kingdom | 2 | 4% |
| India | 2 | 4% |
| Italy | 1 | 2% |
| Denmark | 1 | 2% |
| New Zealand | 1 | 2% |
| Mexico | 1 | 2% |
| Other | 6 | 11% |
| Unknown | 23 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 39 | 71% |
| Practitioners (doctors, other healthcare professionals) | 7 | 13% |
| Scientists | 5 | 9% |
| Science communicators (journalists, bloggers, editors) | 4 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 65 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 9 | 14% |
| Student > Master | 5 | 8% |
| Student > Doctoral Student | 4 | 6% |
| Unspecified | 4 | 6% |
| Researcher | 4 | 6% |
| Other | 6 | 9% |
| Unknown | 33 | 51% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 17% |
| Unspecified | 4 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
| Neuroscience | 3 | 5% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Other | 7 | 11% |
| Unknown | 35 | 54% |
Attention Score in Context
This research output has an Altmetric Attention Score of 783. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 March 2024.
All research outputs
#24,903
of 25,738,558 outputs
Outputs from Lancet Neurology
#24
of 4,064 outputs
Outputs of similar age
#721
of 425,059 outputs
Outputs of similar age from Lancet Neurology
#1
of 72 outputs
Altmetric has tracked 25,738,558 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,064 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 425,059 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.